Search
for
Sort by
Research 691–720 of 1000+
- Post-COVID-19 Syndrome Mechanisms, Prevention and Management
- Novel insights into the molecular mechanisms underlying generalized glucocorticoid resistance and hypersensitivity syndromes
- Metabolic syndrome and dermatological diseases: association and treatment
- International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women
- Acquired 11β-hydroxylase Deficiency by Inhaled Etomidate and its Analogues: A Mimic of Congenital Adrenal Hyperplasia
- A Case of Trichorhinophalangeal Syndrome Caused by a Novel Heterozygous Nonsense Mutation in the <i>TRPS1</i> Gene
- Genotype–Phenotype Correlation in Children With Congenital Adrenal Hyperplasia due to 21‐Hydroxylase Deficiency Using Next Generation Sequencing
- Exploring links between acne and metabolic syndrome: a narrative review
- Metabolic Syndrome, Cardiovascular Disease and the Hair Growth Cycle: Addressing hair growth disruptions using Nourkrin® with Marilex® as a proteoglycan replacement therapy: A concise review
- Characteristics of Men Who Report Persistent Sexual Symptoms After Finasteride Use for Hair Loss
- A Clinical Approach to Severe Insulin Resistance
- Dermatosis associated with menopause
- Food and medicine homology: a potential nutritional intervention strategy for post-acute COVID-19 syndrome
- 9. Immunology and Genetics
- Insight into the pathogensis of polycystic ovarian syndrome
- Case Report:Pregnancy and birth in a mild phenotype of Alström syndrome
- Effect of finasteride on the ovulatory function of normal women
- The Performance of Glycated Hemoglobin vs. Oral Glucose Tolerance Test in the Diagnosis of Glycemic Disorders among Women with Polycystic Ovary Syndrome in Southern Iraq
- Premature Greying of Hair (Premature Canities): A Concern for Parent and Child
- Congenital Adrenal Hyperplasia
- Hair Supplements
- Multidimensional assessment of adverse events of finasteride：a real-world pharmacovigilance analysis based on FDA Adverse Event Reporting System (FAERS) from 2004 to April 2024
- Investigation, Treatment, and Monitoring of Late‐Onset Hypogonadism in Males: ISA, ISSAM, and EAU Recommendations
- COVID-19 and hypopituitarism
- Testicular Steroidogenesis
- Corticotropin releasing factor-1 receptor antagonism associated with favorable outcomes of male reproductive health biochemical parameters
- Women Also Use 5α-Reductase Inhibitors
- Androgen Treatment in Adolescent Males With Hypogonadism
- Advances in mitochondria-centered mechanism behind the roles of androgens and androgen receptor in the regulation of glucose and lipid metabolism
- Alternative androgen pathways